298
Participants
Start Date
October 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
Ziprasidone
Oral capsule formulation to be administered every day for duration of patient's participation in the trial - 40 mg on Day 1; 40 mg twice a day (BID) on Day 2; Flexible BID dosing of 40 mg, 60 mg, 80 mg, 100 mg, 120 mg, 140 mg or 160 mg total daily dose from Day 3 through Week 6. Dose increases of up to 40 mg/day can occur after subject has received previous lower dose for at least 1 day.
Placebo
Matching placebo oral capsules to be administered as per the instructions for the ziprasidone arm
Pfizer Investigational Site, Westmead
Pfizer Investigational Site, Richmond
Pfizer Investigational Site, Spring Hill
Pfizer Investigational Site, Everton Park
Pfizer Investigational Site, New York
Pfizer Investigational Site, Staten Island
Pfizer Investigational Site, Glen Oaks
Pfizer Investigational Site, Brooklyn
Pfizer Investigational Site, Rochester
Pfizer Investigational Site, Olean
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Rockville
Pfizer Investigational Site, Charlottesville
Pfizer Investigational Site, Chapel Hill
Pfizer Investigational Site, Sanford
Pfizer Investigational Site, Orlando
Pfizer Investigational Site, West Palm Beach
Pfizer Investigational Site, Boca Raton
Pfizer Investigational Site, St. Petersburg
Pfizer Investigational Site, Memphis
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Dayton
Pfizer Investigational Site, Greenwood
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Clinton Township
Pfizer Investigational Site, Brown Deer
Pfizer Investigational Site, Skokie
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Saint Charles
Pfizer Investigational Site, Topeka
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Lincoln
Pfizer Investigational Site, Lake Charles
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Springdale
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Oklahoma City
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Lake Jackson
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Austin
Pfizer Investigational Site, Chandler
Pfizer Investigational Site, Litchfield Park
Pfizer Investigational Site, Torrance
Pfizer Investigational Site, Oceanside
Pfizer Investigational Site, San Diego
Pfizer Investigational Site, Costa Mesa
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Kirkland
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Richland
Pfizer Investigational Site, Delhi
Pfizer Investigational Site, Aurangabad
Pfizer Investigational Site, Boca Raton
Pfizer Investigational Site, Jacksonville
Pfizer Investigational Site, Boston
Pfizer Investigational Site, Watertown
Pfizer Investigational Site, St Louis
Pfizer Investigational Site, Nashua
Pfizer Investigational Site, Cherry Hill
Pfizer Investigational Site, Clementon
Pfizer Investigational Site, Cincinnati
Pfizer Investigational Site, Ellisbridge
Pfizer Investigational Site, Ahmedabad
Pfizer Investigational Site, Pune
Pfizer Investigational Site, Pune
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY